Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 3, 2001Journal of Medicinal ChemistryOpen Access

Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further SAR Studies and Identification of a Novel Orally Bioavailable Hydrazine-Based Antiviral Agent

View Full Paper
Ask AI
Bookmark
Share

Authors

GCGiuseppe CampianiUniversity of SienaFAFrancesca AielloUniversity of CalabriaMFMonica FabbriniUniversity of Pisa

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Campiani et al. (2001) studied this question.

synapsesocial.com/papers/6a912db287dfe5d232f125aahttps://doi.org/10.1021/jm0010365
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Novel and Highly Potent 5-HT3 Receptor Agonists Based on a Pyrroloquinoxaline Structure1997 · 71 citations
  2. 2Urea−PETT Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 3. Synthesis and Further Structure−Activity Relationship Studies of PETT Analogues1999 · 89 citations
  3. 3Substrate specificity of isopenicillin N synthase1992 · 34 citations
  4. 4<i>Trans</i> -Acting Transcriptional Activation of the Long Terminal Repeat of Human T Lymphotropic Viruses in Infected Cells1984 · 779 citations
  5. 5The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase1995 · 94 citations